Cost effectiveness of interferon alpha or peginterferon alpha with ribavirin for histologically mild chronic hepatitis C.

@article{Grieve2006CostEO,
  title={Cost effectiveness of interferon alpha or peginterferon alpha with ribavirin for histologically mild chronic hepatitis C.},
  author={Richard D Grieve and Jonathan Roberts and Mark Wright and Michael Sweeting and Dan D Deangelis and William Rosenberg and Margaret Fiona Bassendine and Janice Main and Howard Thomas},
  journal={Gut},
  year={2006},
  volume={55 9},
  pages={1332-8}
}
BACKGROUND For patients with mild chronic hepatitis C the cost effectiveness of antiviral therapy is unknown. AIMS To assess whether antiviral therapy (either interferon alpha or peginterferon alpha combined with ribavirin) is cost effective at a mild stage compared with waiting and only treating those cases who progress to moderate disease. PATIENTS Cases with mild chronic hepatitis C. METHODS A cost effectiveness model which estimates long term costs and outcomes for patients with mild… CONTINUE READING
42 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 42 extracted citations

Similar Papers

Loading similar papers…